The Butrans transdermal patch is already available in 5mcg/hour, 10mcg/hour, 15mcg/hour and 20mcg/hour strengths. The new dose is expected to launch in October 2014. For more information call (888 ...

Results showed that of those who completed the study, the buprenorphine group had 86.3% who experienced a 30% reduction in average versus baseline pain at week 12, compared with the 56.6% in the ...

The new 15-microgram/hour dosage strength of the once-weekly buprenorphine transdermal system (Butrans) joins the 5-, 10-, and 20-microgram/hour strengths already available.

Higher buprenorphine doses prevent hospitalization of people with fentanyl addiction, study finds Exceeding the standard dose helped more patients stay in treatment Manage alerts for this article ...

STAMFORD, Conn. — The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday. Purdue announced the approval ...

METHODOLOGY: The cohort study analyzed data from 126 adults (median age, 35 years; 71% men; 52% White individuals) with OUD who self-reported daily fentanyl use across 175 buprenorphine initiation ...

They knew that buprenorphine could help people stop using opioids, but it was much harder to start the treatment for those who used fentanyl, which lasts longer in the body.

It’s tricky because buprenorphine activates the brain’s opioid receptors at only a 60% level. If fentanyl remains in the system, activating receptors at a higher level, ...